Cart
sales@molnova.com
Bivatuzumab
CAS No. 214559-60-1
Bivatuzumab( —— )
Catalog No. M36909 CAS No. 214559-60-1
Bivatuzumab (BIWA 4) is a humanized monoclonal antibody against CD44v6.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 375 | Get Quote |
|
| 5MG | 615 | Get Quote |
|
| 10MG | 938 | Get Quote |
|
| 25MG | 1408 | Get Quote |
|
| 50MG | 1822 | Get Quote |
|
| 100MG | 2502 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameBivatuzumab
-
NoteResearch use only, not for human use.
-
Brief DescriptionBivatuzumab (BIWA 4) is a humanized monoclonal antibody against CD44v6.
-
DescriptionBivatuzumab (Anti-CD44 Recombinant Antibody; BIWA 4) is a humanized monoclonal antibody directed against CD44v6. CD44v6 could acts as a sarcoma target for CAR-redirected CIK cells.
-
In VitroBivatuzumab (10 μg/mL) stains CD44v6 in STS cells.
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number214559-60-1
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Leuci V,et al. CD44v6 as innovative sarcoma target for CAR-redirected CIK cells. Oncoimmunology. 2018 Feb 15;7(5):e1423167. ?
molnova catalog
related products
-
NLRP3/AIM2-IN-2
NLRP3/AIM2-IN-2 is a novel potent inhibitor with different species-specific effects on NLRP3 and AIM2 inflammasome dependent pyroptosis with IC50 of 0.2392 ± 0.0233 μ M.
-
γ-Decalactone
γ-Decalactone is a natural compound.
-
Diminazene Aceturate
Diminazene, also known as Diminazine, 4,4’-(Diazoamino)benzamidine, 4,4’-(1-Triazene-1,3-diyl)bis-benzenecarboximidamide, Diminazine aceturate, or Diminazene aceturate, is a trypanocidal agent.
